290 related articles for article (PubMed ID: 28223277)
1. Ventricular arrhythmias and sudden death in patients taking ibrutinib.
Lampson BL; Yu L; Glynn RJ; Barrientos JC; Jacobsen ED; Banerji V; Jones JA; Walewska R; Savage KJ; Michaud GF; Moslehi JJ; Brown JR
Blood; 2017 May; 129(18):2581-2584. PubMed ID: 28223277
[No Abstract] [Full Text] [Related]
2. Addition of venetoclax at time of progression in ibrutinib-treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare.
Hampel PJ; Call TG; Ding W; Muchtar E; Kenderian SS; Wang Y; Leis JF; Witzig TE; Koehler AB; Fonder AL; Schwager SM; Rabe KG; Van Dyke DL; Braggio E; Slager SL; Kay NE; Parikh SA
Am J Hematol; 2020 Mar; 95(3):E57-E60. PubMed ID: 31788844
[No Abstract] [Full Text] [Related]
3. Ibrutinib induced acute tubular injury: A case series and review of the literature.
Manohar S; Bansal A; Wanchoo R; Sakhiya V; Lucia S; Jhaveri KD
Am J Hematol; 2019 Sep; 94(9):E223-E225. PubMed ID: 31148235
[No Abstract] [Full Text] [Related]
4. Atypical primary cutaneous cryptococcosis during ibrutinib therapy for chronic lymphocytic leukemia.
Peri AM; Rossio R; Tafuri F; Benzecry V; Grancini A; Reda G; Bandera A; Peyvandi F
Ann Hematol; 2019 Dec; 98(12):2847-2849. PubMed ID: 31741032
[No Abstract] [Full Text] [Related]
5. Seasonal Influenza Vaccination in Patients With Chronic Lymphocytic Leukemia Treated With Ibrutinib.
Sun C; Gao J; Couzens L; Tian X; Farooqui MZ; Eichelberger MC; Wiestner A
JAMA Oncol; 2016 Dec; 2(12):1656-1657. PubMed ID: 27533065
[No Abstract] [Full Text] [Related]
6. Ibrutinib has some activity in Richter's syndrome.
Giri S; Hahn A; Yaghmour G; Martin MG
Blood Cancer J; 2015 Jan; 5(1):e277. PubMed ID: 25635530
[No Abstract] [Full Text] [Related]
7. Probable Invasive Pulmonary Cryptococcosis and Possible Cryptococcal Empyema in CLL Treated With Frontline Ibrutinib.
Koehler AB; Vijayvargiya P; Ding W
Mayo Clin Proc; 2019 May; 94(5):915-917. PubMed ID: 31054610
[No Abstract] [Full Text] [Related]
8. Dose-limiting stomatitis associated with ibrutinib therapy: a case series.
Vigarios E; Beylot-Barry M; Jegou MH; Oberic L; Ysebaert L; Sibaud V
Br J Haematol; 2019 May; 185(4):784-788. PubMed ID: 30408164
[No Abstract] [Full Text] [Related]
9. Autoimmune cytopenias in patients with chronic lymphocytic leukemia treated with ibrutinib.
Vitale C; Ahn IE; Sivina M; Ferrajoli A; Wierda WG; Estrov Z; Konoplev SN; Jain N; O'Brien S; Farooqui M; Keating MJ; Wiestner A; Burger JA
Haematologica; 2016 Jun; 101(6):e254-8. PubMed ID: 27013651
[No Abstract] [Full Text] [Related]
10. Clinically indicated ibrutinib dose interruptions and reductions do not compromise long-term outcomes in CLL.
Ahn IE; Basumallik N; Tian X; Soto S; Wiestner A
Blood; 2019 May; 133(22):2452-2455. PubMed ID: 30917955
[No Abstract] [Full Text] [Related]
11. Ibrutinib rash in a patient with 17p del chronic lymphocytic leukemia.
Mannis G; Wu D; Dea T; Mauro T; Hsu G
Am J Hematol; 2015 Feb; 90(2):179. PubMed ID: 24890909
[No Abstract] [Full Text] [Related]
12. Ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial treatment for younger patients with chronic lymphocytic leukaemia: a single-arm, multicentre, phase 2 trial.
Davids MS; Brander DM; Kim HT; Tyekucheva S; Bsat J; Savell A; Hellman JM; Bazemore J; Francoeur K; Alencar A; Shune L; Omaira M; Jacobson CA; Armand P; Ng S; Crombie J; LaCasce AS; Arnason J; Hochberg EP; Takvorian RW; Abramson JS; Fisher DC; Brown JR;
Lancet Haematol; 2019 Aug; 6(8):e419-e428. PubMed ID: 31208944
[TBL] [Abstract][Full Text] [Related]
13. Ibrutinib in Japanese patients with relapsed/refractory B-cell malignancies: final analysis of phase I study.
Tobinai K; Uchida T; Fukuhara N; Nishikawa T
Int J Hematol; 2019 Mar; 109(3):366-368. PubMed ID: 30623356
[No Abstract] [Full Text] [Related]
14. Ibrutinib-associated oral ulcers.
Thermos G; Tosios KI
Oral Oncol; 2020 Jan; 100():104445. PubMed ID: 31629661
[No Abstract] [Full Text] [Related]
15. What should standard frontline therapy be in older patients with chronic lymphocytic leukemia? Ibrutinib should be standard frontline therapy.
Woyach JA
Clin Adv Hematol Oncol; 2016 May; 14(5):330-3. PubMed ID: 27379693
[No Abstract] [Full Text] [Related]
16. The HELIOS trial protocol: a phase III study of ibrutinib in combination with bendamustine and rituximab in relapsed/refractory chronic lymphocytic leukemia.
Hallek M; Kay NE; Osterborg A; Chanan-Khan AA; Mahler M; Salman M; Wan Y; Sun S; Zhuang SH; Howes A
Future Oncol; 2015; 11(1):51-9. PubMed ID: 24901734
[TBL] [Abstract][Full Text] [Related]
17. Obinutuzumab and ibrutinib induction therapy followed by a minimal residual disease-driven strategy in patients with chronic lymphocytic leukaemia (ICLL07 FILO): a single-arm, multicentre, phase 2 trial.
Michallet AS; Dilhuydy MS; Subtil F; Rouille V; Mahe B; Laribi K; Villemagne B; Salles G; Tournilhac O; Delmer A; Portois C; Pegourie B; Leblond V; Tomowiak C; de Guibert S; Orsini F; Banos A; Carassou P; Cartron G; Fornecker LM; Ysebaert L; Dartigeas C; Truchan Graczyk M; Vilque JP; Aurran T; Cymbalista F; Lepretre S; Lévy V; Nguyen-Khac F; Le Garff-Tavernier M; Aanei C; Ticchioni M; Letestu R; Feugier P
Lancet Haematol; 2019 Sep; 6(9):e470-e479. PubMed ID: 31324600
[TBL] [Abstract][Full Text] [Related]
18. Miliary tuberculosis after initiation of ibrutinib in chronic lymphocytic leukemia.
Wang SY; Ebert T; Jaekel N; Schubert S; Niederwieser D; Al-Ali HK
Ann Hematol; 2015 Aug; 94(8):1419-20. PubMed ID: 25903044
[No Abstract] [Full Text] [Related]
19. Ibrutinib-associated tumor lysis syndrome in a patient with chronic lymphocytic leukemia.
Kaur V; Mehta P; Johnsurd J; Govindarajan R
Blood; 2014 Nov; 124(23):3503-5. PubMed ID: 25431479
[No Abstract] [Full Text] [Related]
20. Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib.
Ghez D; Calleja A; Protin C; Baron M; Ledoux MP; Damaj G; Dupont M; Dreyfus B; Ferrant E; Herbaux C; Laribi K; Le Calloch R; Malphettes M; Paul F; Souchet L; Truchan-Graczyk M; Delavigne K; Dartigeas C; Ysebaert L;
Blood; 2018 Apr; 131(17):1955-1959. PubMed ID: 29437588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
